Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules.
By A. Ludwig, C. Hundhausen, M. Lambert, N. Broadway, R. Andrews, D. Bickett, M. Leesnitzer, J. Becherer. 2005
379 citations recorded by the source corpus.
Subfields: Immunology and Allergy, Oncology, Radiology, Nuclear Medicine and Imaging
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology and Allergy
In Oncology
Citations in the corpus
- A Disintegrin and Metalloproteinase (ADAM) and ADAM with Thrombospondin Motifs (ADAMTS) Family in Vascular Biology and Disease (2019, background): “,Other inhibitors such as CGS27023, GW280264, and GI254023 exhibit specific inhibitory effect on ADAM-9, 10 and 17 [52].”
- The ADAM metalloproteinases (2008, background): “This compound was used to provide evidence that ADAM-10 is involved in constitutive shedding of IL6R from cells, whereas PMA-stimulated shedding was inhibited by GW280264X, a mixed ADAM10/ADAM-17 inhibitor (Hundhausen et al., 2003; Ludwig et al., 2005) .”
- Extracellular sphingomyelinase activity impairs TNF-α-induced endothelial cell death via ADAM17 activation and TNF receptor 1 shedding (2017, methodology): “1 U/ ml SMase for 3 hours in the presence or absence of the preferential ADAM10 inhibitor GI254023X (GI) and the ADAM10 and -17 inhibitor GW280264 (GW) [24].”
- A Disintegrin and Metalloprotease (ADAM): Historical Overview of Their Functions (2016, background): “Other synthetic inhibitors include CGS 27023, GW280264, and GI254023 displaying a certain degree of specificity for ADAM-9, -10, and -17 [14,80].”